According to TipRanks, Wilkie is an analyst with an average return of -12.0% and a 32.00% success rate. Wilkie covers the Healthcare sector, focusing on stocks such as Pro Medicus Limited, Microba Life Sciences Limited, and Mach7 Technologies.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Microba Life Sciences Limited with a A$0.12 average price target.
Based on Microba Life Sciences Limited’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of A$7.32 million and a GAAP net loss of A$10.56 million. In comparison, last year the company earned a revenue of A$8.08 million and had a GAAP net loss of A$5.74 million
